Overview
Watchlist
Equities
Crypto
Soon
Popular
Cookies
Terms of Service
Privacy Policy
Home
© 2025 FYStats 
Home
Equities
ALGS
Fundamentals

Aligos Therapeutics, Inc.

ALGS

Chart
Fundamentals
Soon
Sentiment
Soon
Options

Revenue

311.00k
▼-295.00k▼-48.68%
3 Months Change

Assets

150.70M
▲80.61M▲115.00%
3 Months Change

Liabilities

34.25M
▼-64.81M▼-65.42%
3 Months Change

Free Cash Flow

-22.39M
▼-1.45M▼-6.90%
12 Months Change

Revenue/Cost Of Revenue

Loading...

Net Profit/Loss

Loading...

Assets/Liabilities

Loading...

Cash Flows

Loading...

Earnings Per Share

Loading...

Outstanding Shares

Loading...

Recent Quarterly and Annual Filings

2024-09-05
Form 8-K
ID: 0001193125-24-214188
2024-08-19
Form 8-K
ID: 0001193125-24-202813
2024-08-08
Form 8-K
ID: 0001193125-24-196966
2024-08-06
Form 10-Q
ID: 0000950170-24-091828
2024-08-06
Form 8-K
ID: 0001171843-24-004482
2024-06-28
Form 8-K
ID: 0001193125-24-172218
2024-05-31
Form 8-K
ID: 0001193125-24-151729
2024-05-22
Form 8-K
ID: 0001193125-24-144929
2024-05-15
Form 8-K
ID: 0001193125-24-139476
2024-05-07
Form 10-Q
ID: 0000950170-24-054497